142 related articles for article (PubMed ID: 22902907)
1. The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis.
Yang J; Gao W; Song NH; Wang W; Zhang JX; Lu P; Hua LX; Gu M
Asian J Androl; 2012 Sep; 14(5):726-31. PubMed ID: 22902907
[TBL] [Abstract][Full Text] [Related]
2. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
3. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
Yan YL; Han F; Tan WM; Wu CP; Qin X
Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
[TBL] [Abstract][Full Text] [Related]
4. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
Kong Q; Li P; Tian Q; Ha MW
Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
[TBL] [Abstract][Full Text] [Related]
5. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
Chen T; Yi SH; Liu XY; Liu ZG
Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
[TBL] [Abstract][Full Text] [Related]
9. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
Zhao E; Cui D; Yuan L; Lu W
Mol Biol Rep; 2012 Apr; 39(4):3471-7. PubMed ID: 21725850
[TBL] [Abstract][Full Text] [Related]
11. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
[TBL] [Abstract][Full Text] [Related]
12. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
[TBL] [Abstract][Full Text] [Related]
13. Association of
Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
[TBL] [Abstract][Full Text] [Related]
14. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
[TBL] [Abstract][Full Text] [Related]
15. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.
Shen W; Hu P; Cao JQ; Liu XX; Shao JH
J Int Med Res; 2014 Oct; 42(5):1065-76. PubMed ID: 25070969
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.
Yang J; Xu DL; Lu Q; Han ZJ; Tao J; Lu P; Wang C; Di XK; Gu M
Asian J Androl; 2012 Jul; 14(4):560-5. PubMed ID: 22504876
[TBL] [Abstract][Full Text] [Related]
17. Association of the
Wang P; Wang M; Li S; Ma L; Xi S; He J
Dis Markers; 2016; 2016():4585484. PubMed ID: 27890964
[TBL] [Abstract][Full Text] [Related]
18. Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis.
Yin L; Shen G; Zhu B
Thorac Cancer; 2020 Mar; 11(3):672-678. PubMed ID: 31970867
[TBL] [Abstract][Full Text] [Related]
19. Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.
Zhuo X; Ye H; Li Q; Xiang Z; Zhang X
Medicine (Baltimore); 2016 Mar; 95(9):e2948. PubMed ID: 26945408
[TBL] [Abstract][Full Text] [Related]
20. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
